TrialJournal of the peripheral nervous system : JPNS2024

Long-term safety and tolerability of hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the ADVANCE-CIDP 3 trial.

Robert D M Hadden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.